Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

Jorg R. Oddens, Maurizio Brausi, Richard Sylvester, +9

European Urology

Urological ResearchUrologyMaintenance Bacillus Calmette-guérinUrologic Cancer EpidemiologyGenitourinary Cancer +6

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Richard Sylvester, Maurizio Brausi, Wim J. Kirkels, +7

European Urology

Urological ResearchUrologyBacillus Calmette-guérinUrologic Cancer EpidemiologyGenitourinary Cancer +7

Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

Adrian P.M. van der Meijden, Richard Sylvester, W. Oosterlinck, +2

European Urology

European OrganisationUrologyMaintenance Bacillus Calmette-guerinUrologic Cancer EpidemiologyUrological Research +6

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

S. Krege, J. Beyer, Rainer Souchon, +77

European Urology

Germ Cell CancerGenitourinary CancerMedicineCancer ManagementEuropean Consensus Conference +7

Renal Vein Anatomy and its Implications for Retroperitoneal Surgery

Wolfgang Hoeltl, W. Hruby, Seyedhossein Aharinejad

The Journal of Urology

UrologyRare AnomaliesComplicated Embryological DevelopmentMedicineRenal Pathology +10

The Side Effects of Bacillus Calmette-Guerin in the Treatment of Ta T1 Bladder Cancer Do Not Predict its Efficacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

Richard Sylvester, Adrian P.M. van der Meijden, W. Oosterlinck, +2

European Urology

European OrganisationUrologyBacillus Calmette-guerinUrological ResearchGenitourinary Cancer +6

Effect of NIH-IV Prostatitis on Free and Free-to-total PSA

Igor Stancik, Werner Lüftenegger, M. Klimpfinger, +2

European Urology

UrologyPsoriatic ArthritisBenign Prostatic HyperplasiaProstatic DiseaseMedicine +1

Testicular Cancer: Prognostic Implications of Vascular Invasion

Wolfgang Hoeltl, D. Kosak, J. Pont, +5

The Journal of Urology

Treatment Decision for Stage I Non‐seminomatous Germ Cell Tumours Based on the Risk Factor “Vascular Invasion”

Wolfgang Hoeltl, J. Pont, D. Kosak, +2

British Journal of Urology

Surgical OncologyCancer ManagementVascular InvasionPathologyExtragonadal Germ Cell Tumours +14

Prevalence and Incidence of Clinical Symptoms of the Retroaortic Left Renal Vein

Stefan Heidler, Stephan Hruby, Stephan Schwarz, +3

Urologia Internationalis